Recent breakthrough in Alzheimer's research like AI model predicting the onset of the condition and a newly approved drug that slows cognitive decline have made progress against a condition that ranked as the 7th-leading cause of death in the US in 2022.

Alzheimer's claimed over 120,000 American lives in 2022, with the mortality rate of 28.9 deaths per 100,000 people, reflecting a nearly 7% decline from 2021, states the Centers for Disease Control and Prevention (CDC).

1 in 9 Americans aged 65 or older are affected by Alzheimer's, which account to 60% to 80%, roughly around 7 million people. Among this group, it was the 6th leading cause of death in 2022.

With the aging population, the number of Alzheimer’s cases is projected to nearly double to 13 million by 2050. The financial toll will rise as well: without treatment breakthroughs, annual health care and long-term care costs for Alzheimer’s and related dementias are expected to soar from $360 billion in 2024 to nearly $1 trillion by 2050, per the Alzheimer’s Association.

As per the CDC data, here are the list of the highest age-adjusted Alzheimer's death rates from 2022:

10. California

This state has an Alzheimer's death rate at 37.5 per 100,000 people, with the number of deaths recorded at 17,363.

9. Texas

This state has an Alzheimer's death rate at 38.8 per 100,000 people, with the number of deaths recorded at 10,427.

8. Georgia

This state has an Alzheimer's death rate at 39.3 per 100,000 people, with the number of deaths recorded at 4,219.

7. Idaho

This state has an Alzheimer's death rate at 39.5 per 100,000 people, with the number of deaths recorded at 848.

6. Utah

This state has an Alzheimer's death rate at 39.8 per 100,000 people, with the number of deaths recorded at 1,057.

5. Louisiana

This state has an Alzheimer's death rate at 40 per 100,000 people, with the number of deaths recorded at 2,094.

4. Arkansas

This state has an Alzheimer's death rate at 41 per 100,000 people, with the number of deaths recorded at 1,577.

3. Washington

This state has an Alzheimer's death rate at 41.6 per 100,000 people, with the number of deaths recorded at 3,695.

2. Alabama

This state has an Alzheimer's death rate at 42.2 per 100,000 people, with the number of deaths recorded at 2,655.

1. Mississippi

This state has an Alzheimer's death rate at 48.5 per 100,000 people, with the number of deaths recorded at 1,679.

What Is Alzheimer's Disease?

Alzheimer's is a severe brain disorder of memory loss and confusion. If it is not diagnosed and managed on time, it can also adversely impact one's mental abilities of learning, thinking, reasoning, remembering, problem-solving, decision-making, and attention.

As per Neha Sinha, Dementia Specialist, CEO and Co-founder of Epoch Elder Care, it is a progressive decline in cognitive abilities, including memory, language, problem-solving and other thinking skills. It is severe enough to interfere with daily life. "It primarily affects older adults, with Alzheimer's being the most common," she says.

Alzheimer's accounts for 60 to 80% of all dementia cases around the world. It is estimated that the prevalence of Alzheimer's worldwide is around 24 million. Dementia is the general term for a range of symptoms that affect cognitive abilities, while Alzheimer's is the most common form of dementia.

Shilpi Saraswat, Clinical Psychologist at Sakra World Hospital, Bengaluru points out that the main risk factors of dementia are age, genetics, long-term health conditions, lifestyle choices such as smoking or excessive alcohol use, one's gender and cognitive reserve.

NHS Flu Cases: Flu season has arrived far earlier than expected this year, and hospitals across England are already seeing a sharp rise in cases. The latest figures show that the number of patients admitted with flu is more than 50 percent higher than the same week last year. During the week starting 24 November, an average of 1,717 people were in hospital with flu each day, including 69 who needed critical care, as per The Independent.

In the same week last year, the total was 1,098 patients, with 39 in critical care. These numbers follow recent warnings from the NHS, which urged vulnerable groups to get their flu jabs as early as possible, as experts fear this could turn into one of the most challenging winters in recent memory. This raises several key questions. What is driving this sudden surge, how severe could the coming months be, and how much protection can the vaccine offer?

NHS Flu Cases: What’s Causing The Flu Surge?

Specialists suspect an altered form of influenza A is behind the early rise in cases. They observed Australia’s recent flu season, which often gives a hint of what lies ahead for the UK, and saw record-breaking infection levels. Alerts also came from the Asia-Pacific region, where Japan announced a flu epidemic in October and schools were temporarily closed.

Flu viruses fall into three groups: influenza A (H1N1), influenza A (H3N2), and influenza B. This year, the main culprit is the H3N2 strain. Flu viruses constantly change through a process called antigenic drift, which is why vaccines are updated each year. In the Northern Hemisphere, the strains for the upcoming winter season are chosen in February.

However, this particular H3N2 strain, known as subclade K, changed more rapidly over the summer and is now considered significantly different from the strain used in the current vaccine, according to the UK Health Security Agency (UKHSA). After reviewing the latest NHS numbers, Sarah Woolnough, chief executive of The King’s Fund, noted that the flu season has “not yet peaked,” adding that it is still uncertain how long this early surge will last.

NHS Flu Cases: How Bad Is It?

Health experts fear that thousands of people could lose their lives this winter. Flu-related deaths more than doubled last year, with the UKHSA estimating 7,757 deaths in England, compared with 3,555 the year before. Deaths among children also rose from 34 to 53. Senior NHS leaders have warned of a very difficult winter ahead. In November, NHS England chief executive Jim Mackey said staff may face “one of the toughest” seasons yet.

He admitted that the prospect of a long, heavy flu season had been a major concern, and current trends suggest that these worries were well founded. Australia recorded its worst flu season on record, with more than 410,000 cases, and the expectation is that the UK may face similar patterns. He added that from December through March, hospitals will likely run at full capacity.

NHS Flu Cases: How Effective Are The Vaccines?

The UKHSA has analysed how well this year’s vaccine is performing by examining whether vaccinated people are less likely to be admitted to hospital with flu. Early assessments show that the vaccine is offering around 70 to 75 percent protection against hospital attendance in children aged two to seventeen, and around 30 to 40 percent protection in adults.

Dr Jamie Lopez Bernal, consultant epidemiologist for immunisation at UKHSA, said he remains confident that the vaccine will provide important protection for those most at risk, regardless of which strain becomes dominant. He explained that practising good respiratory hygiene and reducing contact with others when symptomatic can also help lower transmission. According to NHS England, 14.4 million flu vaccines were administered during the autumn, which is more than 160,000 ahead of the same point last year.

NHS Flu Cases: Should You Get A Flu Vaccine?

Flu vaccinations are free and advised for several groups, including:

• Everyone aged 65 and above
• People under 65 who fall into clinical risk categories
• Residents of care homes and their carers
• Pregnant women
• Close contacts of people who are immunosuppressed
• Frontline health and social care workers
• Children

Vaccinations began in October, but anyone eligible can still get their jab until 31 March.

You can get vaccinated by:

• Making an appointment with your GP surgery
• Booking a free NHS flu jab at a pharmacy through the NHS website or app
• Visiting a pharmacy that offers walk-in NHS flu vaccinations if you are 18 or older

As of 23 November, 69.6 percent of people aged over 65 had received their jab. Uptake was lower in other groups, including adults under 65 with long-term health conditions (35.1 percent), pregnant women (33.9 percent), and children aged two (39.8 percent) and three (40.3 percent).

A federal vaccine advisory group in the United States is preparing to decide whether newborns should continue to receive the hepatitis B vaccine, which was the first shot proven to prevent cancer. The CDC committee is expected to revisit the long-standing guidance from the early 1990s, when the vaccine began to be given within the first 24 hours of life.

As per CNN, advisers to the Centers for Disease Control and Prevention will be voting on Friday to vote on whether the agency should move away from its long-held recommendation that every infant receive the hepatitis B shot shortly after birth. The information below outlines key points everyone should understand about hepatitis B and its vaccine.

What is Hepatitis B?

Hepatitis B is a viral infection that affects the liver. Many adults are able to clear the virus after an acute infection. Some, however, go on to develop chronic hepatitis B, which increases the risk of liver cancer, liver failure and cirrhosis, or permanent scarring of the liver.

People who live with chronic hepatitis B face a much higher chance of dying early. At the ACIP meeting on Thursday, Dr. Sandra Fryhofer, who spoke on behalf of the American Medical Association, described her experience working on a hepatitis B ward during medical school, according to CNN.

She said that those were the sickest patients she had ever encountered. She explained that she has treated people with liver disease caused by hepatitis B, cirrhosis linked to the virus, and liver cancer, as well as deaths related to the infection. Infants and young children who contract hepatitis B are far more likely to develop lifelong disease, including about 90 percent of infected babies and roughly 30 percent of children between one and five years of age.

How Is Hepatitis B Spread?

The hepatitis B virus is highly contagious. It spreads when blood, semen or other bodily fluids from a person who carries the virus enter the body of someone who is not infected.

Certain medical conditions, personal habits and other circumstances can raise the risk, such as injection drug use or sexual contact, but the virus can infect anyone. Hepatitis B can also pass from an infected mother to her baby during childbirth, whether through a vaginal delivery or a C section.

How Common Is Hepatitis B?

Many people living with hepatitis B show no clear symptoms, and more than half may not know they are infected. Recent CDC figures report about 2200 newly documented cases of acute hepatitis B in 2023, although the true number is estimated to be more than six times higher, closer to 14400.

The CDC also estimates that about 640000 adults in the United States have chronic hepatitis B. Worldwide, the World Health Organization reports that 254 million people are living with chronic hepatitis B, with about 1.2 million new infections each year.

Can Hepatitis B Be Treated?

There is no treatment for acute hepatitis B. Some medicines are available for chronic infection. These treatments may need to be taken for life because there is no cure.

How Can Hepatitis B Be Prevented?

Vaccination is the most reliable way to prevent hepatitis B. The shots offer strong protection in infancy and continue to shield individuals well into adulthood.

Most people who live with hepatitis B contracted it as babies or very young children, when their immune systems were not fully developed, according to the CDC. At present, the agency recommends that all infants receive the vaccine at birth before leaving the hospital.

Babies usually receive a three dose series. A scientific review by the Vaccine Integrity Project found that 95 percent of healthy infants develop enough immunity after the third dose. The vaccine also lowers the risk of infection by nearly 70 percent in babies born to mothers who have hepatitis B.

More than 90 per cent of people who completed the vaccine series showed signs of continued protection 30 years later, based on CDC data.

Is The Hepatitis B Vaccine Safe?

According to the Vaccine Integrity Project’s review, giving the hepatitis B shot at birth has consistently proven safe. Only mild and short-lasting reactions have been noted, such as slight swelling or redness at the injection site and low fever. There was no rise in serious life-threatening reactions linked to the vaccine.

Dr. Anthony Fiore, an infectious diseases specialist and former CDC official who worked in the hepatitis division, described it as a very safe vaccine. He said it has been studied thoroughly before and after approval. He added that the United States vaccine safety systems have looked closely at concerns about fever or other chronic problems.

He explained that none of these concerns have been confirmed. No long-term harm has been linked to the vaccine, and nothing comes close to the danger posed by chronic hepatitis B infection.

Most of us do not think twice about our daily driving habits. We take the same turns, choose the same roads, and travel at roughly the same times every day. But according to new research from Washington University in St Louis, these small choices may quietly reflect something deeper happening inside the brain. The findings are published in the journal Neurology.

The study suggests that subtle changes in driving behavior could serve as early warning signs of cognitive decline. In other words, the way an older adult drives today may help predict future memory or thinking problems long before they become obvious.

What the Researchers Found

The team focused on people already diagnosed with mild cognitive impairment, often considered a transitional stage between normal aging and conditions like Alzheimer’s disease. They analyzed data from 56 individuals with mild cognitive impairment and compared it with information from 242 adults of similar age who showed no cognitive issues. The average age in both groups was 75.

Instead of relying only on memory tests or conversations with patients, the researchers added GPS tracking data collected directly from participants' vehicles. This allowed them to understand how often people drove, where they went, what routes they chose, and how they behaved behind the wheel over a period of nearly three and a half years.

What emerged was a pattern. People with mild cognitive impairment gradually began driving less often and to fewer places. They stuck to familiar routes, avoided more complex trips, and showed less variation in the times they traveled. They also tended to speed less. Even after adjusting for factors like age, education level, and genetic risk of Alzheimer’s, the differences in driving habits remained clear.

Driving Behavior as a Diagnostic Tool

The researchers found that driving data alone correctly identified individuals with mild cognitive impairment 82 percent of the time. When combined with standard cognitive tests and demographic information, accuracy rose to 87 percent.

Neurology researcher Ganesh Babulal explained that early identification of unsafe drivers is a public health priority, but the usual evaluation methods can be slow and difficult. According to him, adding GPS tracking to traditional screening tools could offer a practical and more accurate way to spot early cognitive problems.

He noted that daily driving behavior is a low effort and unobtrusive marker of how well someone is functioning. Since driving requires quick thinking, coordination, and attention, even small cognitive changes can influence how people choose to navigate the road.

What Comes Next

The research team plans to expand the study to include larger and more diverse groups of people. They also hope to bring in additional factors, such as vehicle type, where participants live, and other medical conditions.

Their goal is not to take away anyone’s independence but to help identify risks earlier so that support and interventions can be offered before a crash or near miss occurs. At the same time, the researchers stress that any tools developed from this work must balance safety with respect for personal autonomy and privacy.

This study opens an important conversation: sometimes the first signs of cognitive decline do not show up in a doctor’s clinic. They show up quietly, in the everyday paths we choose and the roads we avoid.,